Differential gene expression identifies subgroups of ovarian carcinoma

Translational Research

Volumn 148, Issue 5, 2006, Pages 223-248

  Skubitz, Amy P N ^a   Pambuccian, Stefan E ^a   Argenta, Peter A ^a   Skubitz, Keith M ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; METABOLISM; OVARY CARCINOMA; PAPILLOMA; PATHOLOGIST; PATHOLOGY; PRIORITY JOURNAL;

EID: 33750300204     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2006.06.001     Document Type: Article

References (42)

1. American Cancer Society. Cancer Facts and Figures 2006 (2006), American Cancer Society, Atlanta, GA
2. Seidman J.D., Horkayne-Szakaly I., Haiba M., Boice C.R., Kurman R.J., and Ronnett B.M. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol 23 (2004) 41-44
3. Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?. Gynecol Oncol 72 (1999) 437-442
4. Piek J.M., Kenemans P., and Verheijen R.H. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. Am J Obstet Gynecol 191 (2004) 718-732
5. Rodriguez M., and Dubeau L. Ovarian tumor development: insights from ovarian embryogenesis. Eur J Gynaecol Oncol 22 (2001) 175-183
6. Seidman J.D., Ronnett B.M., and Kurman R.J. Pathology of borderline (low malignant potential) ovarian tumours. Best Pract Res Clin Obstet Gynaecol 16 (2002) 499-512
7. Shih Ie M., and Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164 (2004) 1511-1518
8. Scully R.E. World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer Inst Monogr 42 (1975) 5-7
9. Nielsen T.O., West R.B., Linn S.C., Alter O., Knowling M.A., O'Connell J.X., et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359 (2002) 1301-1307
10. Takahashi M., Yang X.J., Sugimura J., Backdahl J., Tretiakova M., Qian C.N., et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 22 (2003) 6810-6818
11. Skubitz K.M., and Skubitz A.P. Differential gene expression in renal-cell cancer. J Lab Clin Med 140 (2002) 52-64
12. Skubitz K.M., and Skubitz A.P. Differential gene expression in leiomyosarcoma. Cancer 98 (2003) 1029-1038
13. Skubitz K.M., and Skubitz A.P. Characterization of sarcomas by means of gene expression. J Lab Clin Med 144 (2004) 78-91
14. Skubitz K.M., and Skubitz A.P. Gene expression in aggressive fibromatosis. J Lab Clin Med 143 (2004) 89-98
15. Skubitz K.M., Cheng E.Y., Clohisy D.R., Thompson R.C., and Skubitz A.P. Differential gene expression in liposarcoma, lipoma, and adipose tissue. Cancer Invest 23 (2005) 105-118
16. Skubitz K.M., Zimmerman W., Kammerer R., Pambuccian S.E., and Skubitz A.P. Differential gene expression identifies subgroups of renal cell carcinoma. J Lab Clin Med 147 (2006) 250-267
17. Berchuck A., Iversen E.S., Lancaster J.M., Pittman J., Luo J., Lee P., et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res 11 (2005) 3686-3696
18. Bernardini M., Lee C.H., Beheshti B., Prasad M., Albert M., Marrano P., et al. High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer. Neoplasia 7 (2005) 603-613
19. Marquez R.T., Baggerly K.A., Patterson A.P., Liu J., Broaddus R., Frumovitz M., et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11 (2005) 6116-6126
20. Meinhold-Heerlein I., Bauerschlag D., Hilpert F., Dimitrov P., Sapinoso L.M., Orlowska-Volk M., et al. Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 24 (2005) 1053-1065
21. Spentzos D., Levine D.A., Ramoni M.F., Joseph M., Gu X., Boyd J., et al. Gene expression signature with independent prognostic significance in epithelial ovarian cancer. J Clin Oncol 22 (2004) 4700-4710
22. Zorn K.K., Bonome T., Gangi L., Chandramouli G.V., Awtrey C.S., Gardner G.J., et al. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 11 (2005) 6422-6430
23. Fleming J.S., Beaugie C.R., Haviv I., Chenevix-Trench G., and Tan O.L. Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247 (2006) 4-21
24. Hibbs K., Skubitz K.M., Pambuccian S.E., Casey R.C., Burleson K.M., Oegema Jr. T.R., et al. Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol 165 (2004) 397-414
25. Le Page C., Provencher D., Maugard C.M., Ouellet V., and Mes-Masson A.M. Signature of a silent killer: expression profiling in epithelial ovarian cancer. Expert Rev Mol Diagn 4 (2004) 157-167
26. Spentzos D., Levine D.A., Kolia S., Out H., Boyd J., Libermann T.A., et al. Unique gene expression profile based on pathologic response in epithelial ovarian cancer. J Clin Oncol 23 (2005) 7911-7918
27. Ouellet V., Provencher D.M., Maugard C.M., Le Page C., Ren F., Lussier C., et al. Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling. Oncogene 24 (2005) 4672-4687
28. Gilks C.B., Vanderhyden B.C., Zhu S., van de Rijn M., and Longacre T.A. Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling. Gynecol Oncol 96 (2005) 684-694
29. Bell D.A., Longacre T.A., Prat J., Kohn E.C., Soslow R.A., Ellenson L.H., et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol 35 (2004) 934-948
30. Silverberg S.G. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 19 (2000) 7-15
31. Malpica A., Deavers M.T., Lu K., Bodurka D.C., Atkinson E.N., Gershenson D.M., et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 28 (2004) 496-504
32. Shimizu Y., Kamoi S., Amada S., Akiyama F., and Silverberg S.G. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 82 (1998) 893-901
33. Shimizu Y., Kamoi S., Amada S., Hasumi K., Akiyama F., and Silverberg S.G. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features-problems involved in the architectural grading system. Gynecol Oncol 70 (1998) 2-12
34. Sato Y., Shimamoto T., Amada S., Asada Y., and Hayashi T. Prognostic value of histologic grading of ovarian carcinomas. Int J Gynecol Pathol 22 (2003) 52-56
35. Ishioka S., Sagae S., Terasawa K., Sugimura M., Nishioka Y., Tsukada K., et al. Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system. Gynecol Oncol 89 (2003) 447-452
36. Skubitz K.M., and Skubitz A.P. Differential gene expression in uterine leiomyoma. J Lab Clin Med 141 (2003) 297-308
37. Skubitz K.M., Cheng E.Y., Clohisy D.R., Thompson R.C., and Skubitz A.P. Gene expression in giant-cell tumors. J Lab Clin Med 144 (2004) 193-200
38. Bonome T., Lee J.Y., Park D.C., Radonovich M., Pise-Masison C., Brady J., et al. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res 65 (2005) 10602-10612
39. Hauptmann S., and Dietel M. Serous tumors of low malignant potential of the ovary-molecular pathology: part 2. Virchows Arch 438 (2001) 539-551
40. Schaner M.E., Ross D.T., Ciaravino G., Sorlie T., Troyanskaya O., Diehn M., et al. Gene expression patterns in ovarian carcinomas. Mol Biol Cell 14 (2003) 4376-4386
41. Zhang L., Conejo-Garcia J.R., Katsaros D., Gimotty P.A., Massobrio M., Regnani G., et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348 (2003) 203-213
42. Gilks C.B. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol 23 (2004) 200-205